U.S. and Pfizer Are Negotiating Deal for More Vaccine Doses Next Year December 16, 2020 Auto Bot AstraZeneca PLC, Coronavirus (2019-nCoV), European Union, Food and Drug Administration, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Company Inc, Moderna Inc, Oxford University, Pfizer Inc, Sanofi SA, United States Politics and Government, Vaccination and Immunization 0 The Trump administration is discussing helping the drug maker get the raw materials it would need to produce tens of millions of extra doses of its Covid-19 vaccine in the spring.
